News & Updates
Showing Endocrinology articles
Showing

CKM outcomes in HK after reclassifying obesity by the Lancet Commission’s definition
In an observational study of two community-based cohorts in Hong Kong, 6.7 percent of individuals with BMI ≥25 kg/m2 were reclassified as nonobese after applying the Lancet Commission’s definition of obesity. Individuals with clinical obesity had the highest risk of adverse cardiovascular-kidney-metabolic (CKM) outcomes, while those reclassified as nonobese had an intermediate risk.
CKM outcomes in HK after reclassifying obesity by the Lancet Commission’s definition
27 Mar 2026
Albuminuria an important fracture risk predictor in T2D
Albuminuria is an important and independent predictor of hip fractures and major osteoporotic fractures (MOF) in patients with type 2 diabetes (T2D), and the presence of additional metabolic syndrome (MetS)–related traits compounds this fracture risk, particularly in nonobese patients, a population-based retrospective cohort study in Hong Kong has shown.
Albuminuria an important fracture risk predictor in T2D
26 Mar 2026
VA device a valuable add-on to diabetes self-care regimens
A smart speaker appears to have gone beyond its initial capabilities, improving mental health and diabetes-related outcomes in older adults with type 2 diabetes (T2D) in the Brazilian IVAM-ED* trial.






